Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

ATT Stock Surges After Upgrade to Outperform by Wolfe Research

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Radio telecommunications
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

AT&T‘s stock is experiencing a boost in trading as a result of an upgrade from Wolfe Research on March 5, 2024. The upgrade from Peer Perform to Outperform by Wolfe Research has sparked a more optimistic view on AT&T’s performance, leading to a rise of over 2% in recent trading. This upgrade signifies a shift towards a more positive long-term investment outlook for AT&T, with factors such as an improved dividend yield and churn improvement contributing to the increased confidence in the company’s stock.

AT&T (T) Stock Performance Analysis: Strong Momentum and Positive Returns on March 5, 2024

On March 5, 2024, AT&T (T) had a strong performance in the stock market. According to CNN Money, T is currently trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been relatively stable and is showing positive momentum.

The price of T shares increased by $0.40 since the market last closed, representing a 2.41% rise. The stock opened at $17.02, which was $0.22 higher than its previous close. This opening price was a positive sign for investors, indicating that there was strong demand for T shares at the beginning of the trading day.

Overall, T had a solid performance on March 5, 2024, with the stock showing positive price momentum and a significant increase in value. Investors who were holding T shares likely saw a positive return on their investment on that day.

AT&T Stock Performance: Mixed Results in Financial Report for March 5, 2024

On March 5, 2024, AT&T (T) stock performance was closely watched by investors and analysts as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, AT&T reported total revenue of $122.43 billion for the past year, which remained flat compared to the previous year. The fourth-quarter revenue was reported at $32.02 billion, also flat compared to the previous quarter.

AT&T reported a net income of $14.40 billion for the past year, marking a significant increase of 268.93% compared to the previous year. However, the net income for the fourth quarter was reported at $2.19 billion, showing a decrease of 37.4% compared to the previous quarter.

Earnings per share (EPS) for AT&T were reported at $1.97 for the past year, representing a 261.53% increase compared to the previous year. The EPS for the fourth quarter was reported at $0.30, remaining flat compared to the previous quarter.

Overall, AT&T’s financial performance on March 5, 2024, showed mixed results. While the company saw significant growth in net income and EPS compared to the previous year, there was a decline in net income for the fourth quarter. The flat revenue figures indicate that AT&T may be facing challenges in driving revenue growth in a competitive market.

Investors and analysts will continue to closely monitor AT&T’s performance in the coming quarters to see if the company can sustain its growth and address any potential challenges. AT&T’s ability to innovate and adapt to changing market conditions will be crucial in determining its future success in the telecommunications industry.

Tags: T
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Market Capitalization

Inhibikase Therapeutics Receives Buy Rating and Increased Price Target from HC Wainwright Co

Analyzing Short Interest Trends in Mueller Industries

Anticipated Earnings Report and Stock Performance Analysis for Companhia Siderurgica

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com